Angiomatoid Fibrous Histiocytoma: a Single Institution Case-series

Angiomatoid Fibrous Histiocytoma Clinical Trial

Official title:
Angiomatoid Fibrous Histiocytoma: a Single Institution Case-series

Status Completed

Clinical Trial Summary

single institution cases series review of histological and clinical data

Clinical Trial Description

single institution cases series review of histological and clinical data Investigators will retrieve from the archives of the Rizzoli Institute all the cases with a histological diagnosis of Angiomatoid Fibrous Histiocytoma. In all cases with enough available material, immunohistochemistry will be performed on slides/formalin-fixed paraffin-embedded tissue tumor material. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03759327
Study type	Observational
Source	Istituto Ortopedico Rizzoli
Contact
Status	Completed
Phase
Start date	November 30, 2018
Completion date	May 25, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03600649` - Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas	Phase 1
Active, not recruiting	`NCT02180867` - Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery	Phase 2/Phase 3
Enrolling by invitation	`NCT05266196` - A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)	Phase 1/Phase 2